Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
filingDate |
2000-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2003-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2003518950-A |
titleOfInvention |
Method for producing insulin precursor and insulin precursor analog with improved fermentation yield in yeast |
abstract |
(57) [Summary]nPreferably, novel insulin precursors and insulin precursor analogs are provided, comprising a connecting peptide (mini-C-peptide) of up to 15 amino acid residues and at least one Gly. The precursor can be converted to human insulin or a human insulin analog. The precursor typically has a distance between B27 (atomic CG2) and A1 (atomic CA) of 5 ° or less. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010507631-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014097990-A |
priorityDate |
1999-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |